drugset / Trial / NCT03055741
Study of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA)
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of this study is to evaluate the efficacy and safety of DHP1401 in patients with mild-moderate Alzheimer's disease treated with donepezil
Timeline
- Start
- 2016-12-28
- Primary completion
- 2019-02
- Completion
- 2019-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DHP1401 | Unknown | 500 mg | Oral |
| Subject | DHP1401 | Unknown | 1000 mg | Oral |
| Background | Donepezil | Small molecule | 5 mg | Oral |
| Background | Donepezil | Small molecule | 10 mg | Oral |